1.
Imeta
; 3(2): e179, 2024 Apr.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38882498
RESUMEN
The administration of oral antidiabetic drugs (OADs) to patients with type 2 diabetes elicits distinct and shared changes in the gut microbiota, with acarbose and berberine exhibiting greater impacts on the gut microbiota than metformin, vildagliptin, and glipizide. The baseline gut microbiota strongly associates with treatment responses of OADs.